PRLog (Press Release) -
Oct 02, 2007 -
Health Freedom Nutrition announced today the launch of K2 Clear™, one of the first dietary supplements on the market designed to enhance cardiovascular health by combining a unique form of vitamin K with Nattokinase.
Dale Fowkes, CEO of Health Freedom Nutrition, said K2 Clear will provide users with another natural alternative therapy for maintaining cardiovascular health and overall wellness. Said Fowkes, “K2 Clear, like our oral EDTA chelation product, CardioClear®
, provides natural cardiovascular and circulatory support and fills a unique niche in today’s nutraceutical marketplace.”
Clinical studies on menaquineone-
7, one of the types of vitamin K used in K2 Clear, have suggested this important nutrient may be beneficial in reducing arterial plaque buildup (calcification)
and lowering the risk of osteoporosis. The latter benefit is attributed to menaquineone-
7’s possible affect on bone building osteoblasts.
Said Fowkes, “The research suggests that menaquineone-
7 has positive health benefits on calcium metabolism. The scientists believe it can inhibit arterial calcification while promoting calcium buildup in bone. This is very exciting research and I’m pleased to make K2 Clear available to our customers.”
K2 Clear retails for $29.95 for a 60 capsule bottle. The product can be ordered online at www.hfn-usa.com or by calling 800-980-8780.
Health Freedom Nutrition is committed to developing, manufacturing, and marketing high-quality, science-based nutritional supplements and related products that are made with the finest ingredients in small batches to ensure freshness and potency.
These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.
